| Santen SA - Ducressa 1 mg / mL & 5 mg / mL, collyre en solution |
| 68165 | | 01 | | Ducressa 1 mg / mL & 5 mg / mL | | collyre en solution | | S01CA01 | | Dexamethason und Antiinfektiva | | 26.03.2021 | | |
|
| Composition |
| levofloxacinum 5 mg ut levofloxacinum hemihydricum, dexamethasonum 1 mg ut dexamethasoni natrii phosphas, benzalkonii chloridi solutio 0.10 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dodecahydricus, natrii citras dihydricus, natrii hydroxidum aut acidum hydrochloridum dilutum ad pH, aqua ad iniectabile, ad solutionem pro 1 ml corresp. phosphas 4.01 mg. |
| Packungsbestandteile |
| collyre en solution | | | | | | Principe actif | Concentr. |
|---|
| Dexamethasone | 1 mg/ml | | Levofloxacin | 5 mg/ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| Benzalkonii Chloridi Solutio | 0.1 mg/ml | | Disodium Phosphate Dodecahydrate | | | Natrii Citras Dihydricus | | | Sodium Dihydrogenophosphate Monohydrate | | | Natrii Hydroxidum aut Acidum Hydrochloridum Dilutum ad Ph | |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 ml | DDP | DDP | A | | Oui |
|
